Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The discovery of a new way to target and treat the leading genetic contributor to Parkinson's may open the way for a potential new clinical treatment.

None © Shutterstock

Researchers from Department of Physiology, Anatomy and Genetics (DPAG) have identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment.

Parkinson’s is a motor disorder caused by the loss of a specific sub-set of neurons located in the midbrain. Although the underlying mechanisms leading to the death of these neurons is still not well understood, one of the leading theories is that they die as they accumulate protein aggregates.

Read more (University of Oxford website)

Watch an interview with Professor Richard Wade-Martins (DPAG website)

Similar stories

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Cathy Creswell, David Roberts, and Matthew Costa elected Fellows of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology at the Departments of Psychiatry and Experimental Psychology, David Roberts, Professor of Haematology at the Radcliffe Department of Medicine and Consultant Haematologist, and Matthew Costa, Professor of Orthopaedic Trauma Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, have been elected Fellows of the Academy of Medical Sciences.

Susan Lea and Jordan Raff elected Fellows of the Royal Society

Many congratulations to Susan and Jordan for this prestigious honour, recognising their contributions to structural and centrosome biology, respectively